BACKGROUND: Treatment-related factors that influence quality of life (QOL) for women who are diagnosed with breast carcinoma require study. This study was designed to examine the convergent validity of objective and subjective indices of cosmetic and functional status after patients undergo breast-conserving treatment (BCT) and to test the relations of the objective indicators with QOL. METHODS: Women (n = 54 patients) who had received BCT and radiotherapy for Stage 0-II disease for whom the diagnosis duration ranged from 9 months to 18 years completed assessments of background information, perceived cosmetic and functional outcomes, and QOL. They also were administered a clinical breast examination, including objective ratings of arm edema and breast cosmesis. The patients were a subsample from the study reported by the authors in an accompanying article that is presented in this issue. RESULTS: The findings revealed positive cosmetic and functional treatment outcomes, such that 82% of patients had no or minimal arm edema, and 70% of patients evidenced good or excellent cosmetic results. Convergent validity was demonstrated for the objective and subjective assessments of cosmetic and functional treatment outcomes. In addition, women who had more arm edema reported poorer QOL with regard to depressive symptoms (P < 0.05) and fear of disease recurrence (P < 0.05). CONCLUSIONS: The findings from this study and those reported in the accompanying article reveal that functional treatment outcomes, such as arm edema and breast specific pain, are important correlates of QOL even many years after patients undergo BCT and radiotherapy. Both subjective and objective indicators of treatment outcomes are useful predictors of QOL. Copyright 2001 American Cancer Society.
BACKGROUND: Treatment-related factors that influence quality of life (QOL) for women who are diagnosed with breast carcinoma require study. This study was designed to examine the convergent validity of objective and subjective indices of cosmetic and functional status after patients undergo breast-conserving treatment (BCT) and to test the relations of the objective indicators with QOL. METHODS:Women (n = 54 patients) who had received BCT and radiotherapy for Stage 0-II disease for whom the diagnosis duration ranged from 9 months to 18 years completed assessments of background information, perceived cosmetic and functional outcomes, and QOL. They also were administered a clinical breast examination, including objective ratings of arm edema and breast cosmesis. The patients were a subsample from the study reported by the authors in an accompanying article that is presented in this issue. RESULTS: The findings revealed positive cosmetic and functional treatment outcomes, such that 82% of patients had no or minimal arm edema, and 70% of patients evidenced good or excellent cosmetic results. Convergent validity was demonstrated for the objective and subjective assessments of cosmetic and functional treatment outcomes. In addition, women who had more arm edema reported poorer QOL with regard to depressive symptoms (P < 0.05) and fear of disease recurrence (P < 0.05). CONCLUSIONS: The findings from this study and those reported in the accompanying article reveal that functional treatment outcomes, such as arm edema and breast specific pain, are important correlates of QOL even many years after patients undergo BCT and radiotherapy. Both subjective and objective indicators of treatment outcomes are useful predictors of QOL. Copyright 2001 American Cancer Society.
Authors: Alfred C Marcus; Michael A Diefenbach; Annette L Stanton; Suzanne M Miller; Linda Fleisher; Peter C Raich; Marion E Morra; Rosemarie Slevin Perocchia; Zung Vu Tran; Mary Anne Bright Journal: J Health Commun Date: 2013-02-28
Authors: Maria Jose Cortes-Mateos; David Martin; Sergio Sandoval; Manuel E Ruidiaz; Davorka Messmer; Jessica Wang-Rodriguez; William Trogler; Andrew C Kummel; Sarah L Blair Journal: Ann Surg Oncol Date: 2009-01-10 Impact factor: 5.344
Authors: Gary M Freedman; Penny R Anderson; Richard J Bleicher; Samuel Litwin; Tianyu Li; Ramona F Swaby; Chang-Ming Charlie Ma; Jinsheng Li; Elin R Sigurdson; Deborah Watkins-Bruner; Monica Morrow; Lori J Goldstein Journal: Int J Radiat Oncol Biol Phys Date: 2012-05-12 Impact factor: 7.038
Authors: Julius K Weng; Xiudong Lei; Pamela Schlembach; Elizabeth S Bloom; Simona F Shaitelman; Isidora Y Arzu; Gregory Chronowski; Tomas Dvorak; Emily Grade; Karen Hoffman; George Perkins; Valerie K Reed; Shalin J Shah; Michael C Stauder; Eric A Strom; Welela Tereffe; Wendy A Woodward; Gabriel N Hortobagyi; Kelly K Hunt; Thomas A Buchholz; Benjamin D Smith Journal: Int J Radiat Oncol Biol Phys Date: 2021-05-13 Impact factor: 8.013
Authors: Grit Welzel; Angela Boch; Elena Sperk; Frank Hofmann; Uta Kraus-Tiefenbacher; Axel Gerhardt; Marc Suetterlin; Frederik Wenz Journal: Radiat Oncol Date: 2013-01-07 Impact factor: 3.481
Authors: Sandra D Scherer; Jochen Bauer; Anja Schmaus; Christian Neumaier; Carsten Herskind; Marlon R Veldwijk; Frederik Wenz; Jonathan P Sleeman Journal: PLoS One Date: 2016-09-02 Impact factor: 3.240